Experimental cancer 'smart bomb' drug targets cells, may extend women's lives
By Marilynn Marchione
Associated PressAssociated Press
Associated PressAssociated Press
Posted: 06/03/2012 12:01:00 AM CDT
June 3, 2012 7:19 AM GMTUpdated: 06/03/2012 02:18:21 AM CDT
CHICAGO -- Doctors have successfully dropped the first "smart bomb" on breast cancer, using a drug to deliver a toxic payload to tumor cells while leaving healthy ones alone.
In a key test involving nearly 1,000 women with very advanced disease, the experimental treatment extended by several months the time women lived without their cancer getting worse, doctors planned to report Sunday, June 3, at a cancer conference in Chicago.
More importantly, the treatment seems likely to improve survival; it will take more time to know for sure. After two years, 65 percent of women who received it were still alive, versus 47 percent of those in a comparison group given two standard cancer drugs./.../
More importantly, the treatment seems likely to improve survival; it will take more time to know for sure. After two years, 65 percent of women who received it were still alive, versus 47 percent of those in a comparison group given two standard cancer drugs./.../
No comments:
Post a Comment